Targeting Homogentisate Dioxygenase Dysfunction in Alkaptonuria: Investigating Curcuma longa’s Therapeutic Potential


Year : 2024 | Volume : 02 | Issue : 02 | Page : 1-11
    By

    Anuradha N Gangapur,

  1. Student, Department of Bioinformatics, BioNome, Bengaluru, Karnataka, India

Abstract

Objectives: Alkaptonuria is known to have a faulty gene HGO in the metabolic process. In the present research work, the focus is towards investigating the therapeutic capabilities of the Curcuma longa upon the faulty Homogentisate dioxygenase gene using ligand-protein binding, which would assist in the corrective tyrosine metabolism. Methods: This study is based on the computational approach using different phytochemicals for evaluation of the potency against the abnormal Homogentisate dioxygenase gene. The database of protein PDB databank was used for the protein retrieval. The structural evaluation on the secondary aspect was considered and ligand with suitable pursuit was done to visualise their binding on two dimensions by performing molecular docking using Pyrx and visualization through the BIOVIA discovery studio. Results: The Docking results of the Ligand and protein reported that the selected phytochemical compounds of Curcuma longa have a potential binding affinity with the Homogentisate dioxygenase ligand. The resultant docking previewed to have two compounds to have a high binding affinity with (-7.2) both, which proposes to have good efficacy of the drug. Conclusion: The selected compounds in the present research work that is Curcuma longa exhibit to have better efficacy of drug in treating the faulty gene in the tyrosine metabolism in Alakptonuria by revealing high binding affinity.

Keywords: Alkaptonuria, homogentisate Dioxygenase, Curcuma longa, faulty metabolic gene, phytochemical compounds, binding affinity, molecular docking.

[This article belongs to International Journal of Biochemistry and Biomolecule Research (ijbbr)]

How to cite this article:
Anuradha N Gangapur. Targeting Homogentisate Dioxygenase Dysfunction in Alkaptonuria: Investigating Curcuma longa’s Therapeutic Potential. International Journal of Biochemistry and Biomolecule Research. 2024; 02(02):1-11.
How to cite this URL:
Anuradha N Gangapur. Targeting Homogentisate Dioxygenase Dysfunction in Alkaptonuria: Investigating Curcuma longa’s Therapeutic Potential. International Journal of Biochemistry and Biomolecule Research. 2024; 02(02):1-11. Available from: https://journals.stmjournals.com/ijbbr/article=2024/view=190679


Browse Figures

References

1. Davison AS, Hughes AT, Milan AM, Sireau N, Gallagher JA, Ranganath LR. Alkaptonuria–Many questions answered, further challenges beckon. Ann Clin Biochem. 2020 Mar;57(2):106–20.
2. Zatkova A, Ranganath L, Kadasi L. Alkaptonuria: current perspectives. The application of clinical genetics. 2020 Jan 23:37–47.
3. Davison AS, Norman BP. Alkaptonuria–Past, present and future. Advc Clncl Chem. 2023 Jan 1;114:47–81.
4. Genovese F, Frederiksen P, Bay-Jensen AC, Karsdal MA, Milan AM, Olsson B, et al. Nitisinone treatment affects biomarkers of bone and cartilage remodelling in alkaptonuria patients. Int Molecular Sci. 2023 Jul 1;24(13):10996.
5. Jenkins BD, Fischer CG, Polito CA, Maiese DR, Keehn AS, Lyon M, et al. The 2019 US medical genetics workforce: a focus on clinical genetics. Genet Med. 2021 Aug 1;23(8):1458–64.
6. Titus GP, Mueller HA, Burgner J, Rodríguez de Córdoba S, Peñalva MA, Timm DE. Crystal structure of human homogentisate dioxygenase. Natur Struct Bio. 2000 Jul;7(7):542–6
7. Chanda S, Ramachandra TV. Phytochemical and pharmacological importance of turmeric (Curcuma longa): A review. Research & Reviews: J Pharma. 2019 Feb;9(1):16–23.
8. Vo TS, Vo TT, Vo TT, Lai TN. Turmeric (Curcuma longa L.): Chemical components and their effective clinical applications. J Turkish Chem Society Section A: Chemistry. 2021;8(3):883–98.
9. Ibáñez MD, Blázquez MA. Curcuma longa L. Rhizome essential oil from extraction to its agri-food applications. A review. Plants. 2020 Dec 28;10(1):44.
10. Tam B, Sinha S, Wang SM. Combining Ramachandran plot and molecular dynamics simulation for structural-based variant classification: Using TP53 variants as model. Computl Structl Biotech J. 2020 Jan 1;18:4033–9.
11. Ekins S, Waller CL, Swaan PW, Cruciani G, Wrighton SA, Wikel JH. Progress in predicting human ADME parameters in silico. J Pharmaco Toxicolog Meth. 2000 Jul 1;44(1):251–72.
12. Attar S, Bhor S. A Structure-Based Design Approach to Catharanthus roseus Phytoconstituents as Potential Inhibitors of B-Cell Lymphoma 6 Protein. Int J Bioinf Comput Biol. 2023;1:14–34.
13. Morris GM, Lim-Wilby M. Molecular docking. Molecular modeling of proteins. 2008:365–82.
14. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta medica. 1991 Feb;57(01):1–7.
15. Jyotirmayee B, Mahalik G. A review on selected pharmacological activities of Curcuma longa L. Intl J Food Proper. 2022 Dec 31;25(1):1377–98.


Regular Issue Subscription Original Research
Volume 02
Issue 02
Received 08/10/2024
Accepted 13/11/2024
Published 24/12/2024


Loading citations...

Views: 0